Buscar
Mostrando ítems 1-10 de 299
ACELLULAR AND "LOW" PERTUSSIS VACCINES: ADVERSE EVENTS AND THE ROLE OF MUTATIONS
(Inst Medicina Tropical Sao PauloSao PauloBrasil, 2009)
Rare detection of bordetella pertussis pertactin-deficient strains in Argentina
(Centers Disease Control, 2019-11)
Pertussis resurgence had been attributed to waning vaccine immunity and Bordetella pertussis adaptation to escape vaccine-induced immunity. Circulating bacteria differ genotypically from strains used in production of ...
Bordetella pertussis: mapeamento e caracterização dos epitopos da toxina pertussis e pertactina
(Fiocruz/Instituto de Tecnologia em Imunobiológicos, 2018)
Modification of pertussis vaccination schedule in Chile, immunization of special groups and control strategies. Commentary from the Consultive Committee of Immunizations of The Chilean Society of Infectious Diseases
(SOC CHILENA INFECTOLOGIA, 2012)
In Chile, an increased number of notifications of cases of whooping cough was detected at the beginning of October 2010, and maintained through 2012. Accumulated cases during 2011 were 2,581 (15.0 per 100,000), which is ...
Development of improved pertussis vaccine
(Landes Bioscience, 2014-08)
Rates of infection with Bordetella pertussis, the gram-negative bacterium that causes the respiratory disease called whooping cough or pertussis, have not abated and 16 million cases with almost 200,000 deaths are estimated ...